clinical trial · NCT07339748
A Clinical Study of ZL-85FA Tablets
Chengdu Zenitar Biomedical Technology Co., Ltd·phase2·not yet recruiting·n = 51
Advanced Solid TumorZL-85FA tabletsZL-85FA tabletsZL-85FA tabletsZL-85FA tabletsZL-85FA tabletsZL-85FA tabletsZL-85FA tabletsZL-85FA tablets
brief summary
An open-label, multicenter phase I/IIa clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZL-85FA tablets in treating advanced solid tumors
started
Jun 30, 2026
primary completion
Jun 30, 2028
completion
Dec 31, 2028
last updated
Jan 15, 2026
official title
An Open-label, Multicenter Phase I/IIa Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ZL-85FA Tablets in Treating Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol